23 pairs of chromosomes.
One unique you.

Receive an overview of your DNA through
detailed reports, tools and more.

buy online at these select retailers

For kits purchased at a retail store, there is a required lab fee.

The lab fee is for processing your saliva sample and generating your reports.

Two easy ways to discover you.

Choose what's right for you.

See Full List of Reports

$69 lab fee

Ancestry
Service

Experience your ancestry in a new way! Get a breakdown of your global ancestry by percentages, connect with DNA relatives and more.

recommended

$169 lab fee

Health + Ancestry Service

Get an even more comprehensive understanding of your genetics. Receive 75+ online reports on your ancestry, traits and health - and more.

You can always upgrade to the Health + Ancestry Service at a later time - once you've received your Ancestry reports.

Please note that you can save $25 today by purchasing the Health + Ancestry Service for $100 more.
Or you can add Health reports later for $125.**

Thinking about gifting? You can cover the cost of a lab free with a gift card.

Saliva Collection

How it works

For kits purchased from a retailer

  1. Pay required lab fee online

    Go online and register your kit using the saliva tube barcode so we know it belongs to you. Choose from our Health + Ancestry or Ancestry services. Pay the required lab fee - $69 for Ancestry and $169 for Health + Ancestry. Our lab will not process your sample and you will not receive your reports until you have registered and your payment is received.

  2. Spit

    Follow kit instructions to spit in the tube provided and mail it back to our lab in the pre-paid package.

  3. Discover

    After we analyze your sample, we will send you an email to let you know your reports are ready in your online account. Log in and start discovering what your DNA says about you.

Hi. Still have questions?

Here are just a few of the things people frequently ask about 23andMe.
If you don't see your question here, get in touch with us.

FAQ

FAQs

*The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001) for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. The relevance of each report may vary based on ethnicity. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person's overall risk of developing the disease. These reports are not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication or how much of a medication you should take. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future or anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For Gaucher Disease Type 1, we provide a single report that includes information on both carrier status and genetic health risk. The Celiac Disease genetic health risk report (i) is indicated for reporting of the rs2187668 variant in the HLA-DQA1 gene, which tags the HLA-DQ2.5 haplotype; and the rs7454108 variant near the HLA-DQB1 gene, which tags the HLA-DQ8 haplotype, (ii) describes if a person has variants associated with a higher risk of developing celiac disease. (iii) The variants included in this test are most common and best studied in people of European descent. The Late-onset Alzheimer's Disease genetic health risk report is indicated for reporting of the ε4 variant in the APOE gene and describes if a person has a variant associated with an increased risk of developing late-onset Alzheimer's disease. The ε4 variant included in this report is found and has been studied in many ethnicities. Detailed risk estimates have been studied the most in people of European descent. The Parkinson's Disease genetic health risk report (i) is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene, (ii) describes if a person has variants associated with an increased risk of developing Parkinson's disease, and (iii) is most relevant for people of European, Ashkenazi Jewish, and North African Berber descent. The Cystic Fibrosis carrier status report is indicated for the detection of 28 variants in the CFTR gene and is most relevant for people of Ashkenazi Jewish, European, and Hispanic/Latino descent. The Sickle Cell Anemia carrier status report is indicated for the detection of the HbS variant in the HBB gene and is most relevant for people of African descent. The carrier status reports related to hereditary hearing loss consist of two tests – one indicated for the detection of two variants in the GJB2 gene which is most relevant for people of Ashkenazi Jewish and European descent, and one indicated for the detection of six variants in the SLC26A4 gene.

**Savings based on regular upgrade price of $125. We may offer special discounted upgrades from time to time.

Already have a kit?

Register & pay lab fee

Welcome

Remember, for kits purchased from a retail store:

There is a required lab fee for processing your saliva sample and generating your reports.